Literature DB >> 26459880

Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients.

Bastiaan H Wittekamp1, David S Y Ong2,3,4,5, Olaf L Cremer6, Marc J M Bonten1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26459880     DOI： 10.1007/s00134-015-4081-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?

Authors:  Philippe Eggimann; Michel Wolff; Jorge Garbino
Journal:  Intensive Care Med       Date:  2005-09-30       Impact factor: 17.440

2.  Decontamination of the digestive tract and oropharynx in ICU patients.

Authors:  A M G A de Smet; J A J W Kluytmans; B S Cooper; E M Mascini; R F J Benus; T S van der Werf; J G van der Hoeven; P Pickkers; D Bogaers-Hofman; N J M van der Meer; A T Bernards; E J Kuijper; J C A Joore; M A Leverstein-van Hall; A J G H Bindels; A R Jansz; R M J Wesselink; B M de Jongh; P J W Dennesen; G J van Asselt; L F te Velde; I H M E Frenay; K Kaasjager; F H Bosch; M van Iterson; S F T Thijsen; G H Kluge; W Pauw; J W de Vries; J A Kaan; J P Arends; L P H J Aarts; P D J Sturm; H I J Harinck; A Voss; E V Uijtendaal; H E M Blok; E S Thieme Groen; M E Pouw; C J Kalkman; M J M Bonten
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

3.  Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.

Authors:  Evert de Jonge; Marcus J Schultz; Lodewijk Spanjaard; Patrick M M Bossuyt; Margaretha B Vroom; Jacob Dankert; Jozef Kesecioglu
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

4.  Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study.

Authors:  David S Y Ong; Peter M C Klein Klouwenberg; Cristian Spitoni; Marc J M Bonten; Olaf L Cremer
Journal:  Crit Care       Date:  2013-10-11       Impact factor: 9.097
  4 in total
  3 in total

1.  Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.

Authors:  Catalina Sánchez-Ramírez; Silvia Hípola-Escalada; Miriam Cabrera-Santana; María Adela Hernández-Viera; Liliana Caipe-Balcázar; Pedro Saavedra; Fernando Artiles-Campelo; Nayra Sangil-Monroy; Carlos Federico Lübbe-Vázquez; Sergio Ruiz-Santana
Journal:  Crit Care       Date:  2018-05-30       Impact factor: 9.097

Review 2.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

3.  Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.

Authors:  Denise van Hout; Nienke L Plantinga; Patricia C Bruijning-Verhagen; Evelien A N Oostdijk; Anne Marie G A de Smet; G Ardine de Wit; Marc J M Bonten; Cornelis H van Werkhoven
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.